Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

0.0000 0 (%)

Data as of Aug 17, 2019

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade PTX stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Action	Current	Target
8/12/16	Downgrades	BuyHold
3/17/16	Downgrades	OutperformPerform
3/11/16	Maintains	Buy	5.0

The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings Shanthi RexalineTue, 05 Mar 2019 08:24:27 -0400
81 Biggest Movers From Friday Lisa LevinMon, 04 Mar 2019 06:39:48 -0400
64 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 01 Mar 2019 14:18:25 -0400
Pernix Therapeutics shares are trading lower on continued weakness after the company late Wednesday announced it has filed voluntary petitions commencing cases under Chapter 11 bankruptcy. Benzinga NewsdeskFri, 01 Mar 2019 14:09:22 -0400
Pernix Therapeutics shares down below the $0.30 following news late Wednesday the company began proceedings for voluntary Chapter 11 bankrtupcy. Benzinga NewsdeskThu, 28 Feb 2019 10:31:31 -0400
Pernix Therapeutics 8-K From Late Wed., Showed Co. Filed Voluntary Petitions Commencing Cases Under Chapter 11 Of Title 11 In Bankruptcy Court Benzinga NewsdeskThu, 28 Feb 2019 10:30:51 -0400
Top 15 Most-Volatile Stocks For Thurs., Feb. 21, 2019 Via Benzinga's Securities Lending Volatility Index Powered By Tidal Markets Benzinga NewsdeskThu, 21 Feb 2019 11:25:53 -0400
71 Biggest Movers From Yesterday Lisa LevinWed, 20 Feb 2019 05:49:02 -0400
Mid-Afternoon Market Update: Jeld-Wen Rises On Earnings Beat; Pernix Therapeutics Shares Tumble Lisa LevinTue, 19 Feb 2019 15:24:37 -0400
54 Stocks Moving In Tuesday's Mid-Day Session Lisa LevinTue, 19 Feb 2019 14:01:54 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management Globe NewswireFeb 19, 2019
Detailed Research: Economic Perspectives on Pernix Therapeutics, Hallador Energy, Vince Holding, Tuesday Morning, Information Services Group, and Sienna Biopharmaceuticals — What Drives Growth in Today's Competitive Landscape Globe NewswireNov 13, 2018
Pernix® Therapeutics Reports Third Quarter 2018 Financial Results Globe NewswireNov 08, 2018
Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8 Globe NewswireNov 02, 2018
Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8 Globe NewswireNov 02, 2018
Pernix Therapeutics Holdings, Inc.'s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek® Globe NewswireSep 12, 2018
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek® Globe NewswireAug 27, 2018
Pernix Therapeutics Reports Second Quarter 2018 Financial Results Globe NewswireAug 09, 2018
Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility Globe NewswireAug 01, 2018
Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9 Globe NewswireJul 31, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Bargain hunters drive Pernix up 47% Seeking AlphaFeb 21, 2019
Microcaps dominate midday movers Seeking AlphaFeb 19, 2019
CHF Solutions and MediciNova among healthcare gainers; Pernix Therapeutics leads the losers Seeking AlphaFeb 19, 2019
Pernix files for bankruptcy; shares down 65% Seeking AlphaFeb 19, 2019
UNIT and HIMX among premarket losers Seeking AlphaFeb 19, 2019
Midday movers and shakers Seeking AlphaFeb 15, 2019
Conformis and Avadel Pharmaceuticals among healthcare gainers; Achaogen leads the losers Seeking AlphaFeb 15, 2019
Pernix Therapeutics: It Seems A Serious Sell Seeking AlphaFeb 14, 2019
SIX, MTFB and NTAP among premarket losers Seeking AlphaFeb 14, 2019
GRPN, MDR, DBD and PTX among notable midday movers Seeking AlphaFeb 13, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

PTX $ (%)

Will PTX be a Portfolio Killer in August?

Zacks Investment Research is releasing its prediction for PTX based on the 1-3 month trading system that more than doubles the S&P 500. This report is free today for Benzinga readers. Click here - the PTX analysis is free »

Earnings View Earnings

Q3 2018	EST	Actual	Surprise
EPS:	Expected 2018-11-08
Rev:	Expected 2018-11-08

Q2 2019	EST	Actual	Surprise
EPS:	Expected 2019-08-26
Rev:	Expected 2019-08-26

Fastest Market News Application
You'll Hear It First On Pro

Brokerage Center

Compare All Online Brokerages

Market Overview

Pernix Therapeutics Holdings, Inc. :

Analyst Rating View All Ratings

Earnings View Earnings

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

Pernix Therapeutics Holdings, Inc. :

Analyst Rating View All Ratings

Earnings View Earnings

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners